Overview

The fund targets its investments on equities of companies that are domiciled in Switzerland or are included in the SPI.

Criteria for stock selection include the valuation of the company, the business climate, the company`s positioning and the quality of its management.

The long exposure can go up to 130% and the short exposure to -30%.

Benefits

The aim is to outperform the SPI over the long term. Fluctuations in the value of the fund units may differ substantially from those in the SPI.

Risks

This fund invests in equities and may therefore be subject to high fluctuations in value. As these 麻豆社 funds pursue an active management style, each fund's performance can deviate from that of its reference index. All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. The fund can use derivatives, which may result in additional risks (particularly counterparty risk).

Features

Product category
麻豆社 Country & Regional Funds / Europe
Product domicile
Switzerland
Portfolio management
麻豆社 Asset Management Switzerland AG, Zurich
Fund management
麻豆社 Fund Management (Switzerland) AG
Custodian bank
麻豆社 Switzerland AG, Zurich
Day of inception
December 17, 2004
Currency of account
CHF
Close of financial year
May 31
SFDR Classification
n.a.
Issue / redemption
daily
Distribution
Reinvestment
Maturity
Open end
Ongoing costs p.a.
1.59% p.a.
Management fee
1.00% p.a.
Total expense ratio (TER)
1.07% p.a.
Swing pricing
yes
Minimum investment
n.a.
Reference Index / Benchmark
SPI® (TR) in CHF
Securities no.
1722961
ISIN
CH0017229615
Bloomberg Ticker
CSEQSSA SW
Reuters Id
1722961X.CHE

Performance and Prices

Percentage growth

as of May 27, 2026
Cumulative
CHF(%) EUR(%) USD(%)
YTD 6.32 8.13 7.04
1M
3M
6M
1Y
2Y 15.54 16.53 32.17
3Y
5Y 27.86 53.11 45.89
ø p.a.5Y 5.04 8.89 7.85

Current data
Net asset value 27.05.2026 CHF 46.80
High - last 12 months 27.05.2026 CHF 46.80
Low - last 12 months 25.09.2025 CHF 39.39
Assets of the unit class in mn 27.05.2026 CHF 81.02
Total product assets in mn 27.05.2026 CHF 216.68
Statistical data
Date
2 years
5 years
Total risk reference index / benchmark 30.04.2026 11.72% 12.38%
Sharpe Ratio 30.04.2026 0.59 0.38
Risk Free Rate 30.04.2026 0.40% 0.41%

Structures

By the 10 largest positions (in %, as of April 30, 2026)

 
 
Roche Holding AG 15.70
Nestle SA 13.17
Novartis AG 11.92
麻豆社 Group AG 7.74
ABB Ltd 7.54
Zurich Insurance Group AG 7.12
Swiss Re AG 4.29
Cie Financiere Richemont SA 4.11
Lonza Group AG 2.96
Amrize Ltd 2.81

Fees

Ongoing costs p.a.
1.59%
Flat fee
n.a.
Management fee p.a.
1.00%
Max. redemption commission
2.00%
Max. issuing commission
5.00%
Distribution fee
(see info)

Distributions

No distributions. Continuous reinvestment of income.

Sales Authorisations

Market
Sales authorisations status
Singapore
Institutional Only*
Switzerland
Registered

Literature

en
de
fr
it
es
Brochures
Document type
Document Language
Fact Sheet
en en
de de
it it
fr fr
es es
Manager Commentary
de de
en en
fr fr
Swiss Climate Scores Report
ASIP ESG Report
Fact Sheet - 麻豆社 Country & Regional Funds / Europe
de de
en en
it it
es es
fr fr
Agreement / Prospectus
Document type
Document Language
Prospectus
Key Information Document
Past performance
Previous performance scenario
Annual and semi-annual report (accounting on May 31)
Document type
Document Language
Annual report
Semi-annual report
General information
Document type
Document Language
Tax list
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.